Atlas Trials

Li Zhiming

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Li Zhiming

RecordFirmDate
Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma (NCT07231250)Li Zhiming2026-01-15
Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL (NCT06890585)Li Zhiming2025-06-01
Orelabrutinib Combined With Zuberitamab in the Initial Treatment of MZL (NCT06985472)Li Zhiming2024-11-13
Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma (NCT05422066)Li Zhiming2022-07-26

Track Li Zhiming automatically

Every clearance here is in the API, with alerts when new ones post.